CD133+ cell content correlates with tumour growth in melanomas from skin with chronic sun-induced damage

British Journal of Dermatology

Volumn 169, Issue 4, 2013, Pages 830-837

  Gonzalez Herrero I ^a,b   Romero Camarero, I ^a,b   Canueto J ^b,c   Cardenoso Alvarez E ^d   Fernandez Lopez E ^b,c   Perez Losada J ^a,b   Sanchez Garcia I ^a,b   Roman Curto C ^b,c  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA IBSAL   (Spain)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d HOSPITAL VIRGEN DE LA CONCHA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACRAL LENTIGINOUS MELANOMA; ANTIGEN EXPRESSION; ARTICLE; CANCER STEM CELL; CD133 CELL; CELL COMPOSITION; CELL COUNT; CELL SUBPOPULATION; CELL TYPE; GENETIC HETEROGENEITY; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT LENTIGO; MELANOMA; PHENOTYPE; PRIORITY JOURNAL; SUN EXPOSURE; SUNBURN; SUPERFICIAL SPREADING MELANOMA; TUMOR GROWTH; ULTRAVIOLET RADIATION; CELL PROLIFERATION; CHRONIC DISEASE; COMPARATIVE STUDY; METABOLISM; PATHOLOGY; RADIATION EXPOSURE; RADIATION INJURY; SKIN; SKIN TUMOR; SUNLIGHT;

CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ANTIGENS, CD; CELL PROLIFERATION; CHRONIC DISEASE; GLYCOPROTEINS; HUMANS; MELANOMA; PEPTIDES; RADIATION INJURIES; SKIN; SKIN NEOPLASMS; SUNLIGHT; ULTRAVIOLET RAYS;

EID: 84885585783     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12428     Document Type: Article

References (33)

1. Lens MB, Dawes M,. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004; 150: 179-85.
2. Rigel DS,. Epidemiology of melanoma. Semin Cutan Med Surg 2010; 29: 204-9.
3. Jemal A, Siegel R, Ward E, et al,. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-30.
4. Clark WH Jr, From L, Bernardino EA, Mihm MC,. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969; 29: 705-27.
5. McGovern VJ, Mihm MC Jr, Bailly C, et al,. The classification of malignant melanoma and its histologic reporting. Cancer 1973; 32: 1446-57.
6. Balch CM, Gershenwald JE, Soong SJ, et al,. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199-206.
7. Curtin JA, Fridlyand J, Kageshita T, et al,. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353: 2135-47.
8. Liang Y, Zhong Z, Huang Y, et al,. Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. J Biol Chem 2010; 285: 4931-40.
9. Quintana E, Shackleton M, Sabel MS, et al,. Efficient tumour formation by single human melanoma cells. Nature 2008; 456: 593-8.
10. Klein HM, Ghodsizad A, Marktanner R, et al,. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery. Heart Surg Forum 2007; 10: E66-9.
11. Al Dhaybi R, Sartelet H, Powell J, Kokta V,. Expression of CD133+ cancer stem cells in childhood malignant melanoma and its correlation with metastasis. Mod Pathol 2010; 23: 376-80.
12. Piras F, Perra MT, Murtas D, et al,. The stem cell marker nestin predicts poor prognosis in human melanoma. Oncol Rep 2010; 23: 17-24.
13. Sharma BK, Manglik V, Elias EG,. Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease. J Surg Res 2010; 163: e11-15.
14. Zabierowski SE, Herlyn M,. Melanoma stem cells: the dark seed of melanoma. J Clin Oncol 2008; 26: 2890-4.
15. Monzani E, Facchetti F, Galmozzi E, et al,. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 2007; 43: 935-46.
16. Klein WM, Wu BP, Zhao S, et al,. Increased expression of stem cell markers in malignant melanoma. Mod Pathol 2007; 20: 102-7.
17. Rappa G, Fodstad O, Lorico A,. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 2008; 26: 3008-17.
18. Kim M, Koh YJ, Kim KE, et al,. CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. Cancer Res 2010; 70: 10411-21.
19. Bartolome RA, Ferreiro S, Miquilena-Colina ME, et al,. The chemo-kine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs. Am J Pathol 2009; 174: 602-12.
20. Reya T, Morrison SJ, Clarke MF, Weissman IL,. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-11.
21. Sánchez-García I, Vicente-Dueñas C, Cobaleda C,. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice? BioEssays 2007; 29: 1269-80.
22. Cho RW, Clarke MF,. Recent advances in cancer stem cells. Curr Opin Genet Dev 2008; 18: 48-53.
23. Sekulic A, Haluska P Jr, Miller AJ, et al,. Malignant melanoma in the 21st century: the emerging molecular landscape. Mayo Clin Proc 2008; 83: 825-46.
24. Girouard SD, Murphy GF,. Melanoma stem cells: not rare, but well done. Lab Invest 2011; 91: 647-64.
25. Bastian BC, Kashani-Sabet M, Hamm H, et al,. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res 2000; 60: 1968-73.
26. Bastian BC, Olshen AB, LeBoit PE, Pinkel D,. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 2003; 163: 1765-70.
27. Davies H, Bignell GR, Cox C, et al,. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-54.
28. Kamstrup MR, Gniadecki R, Skovgaard GL,. Putative cancer stem cells in cutaneous malignancies. Exp Dermatol 2007; 16: 297-301.
29. Schatton T, Murphy GF, Frank NY, et al,. Identification of cells initiating human melanomas. Nature 2008; 451: 345-9.
30. Kucia M, Reca R, Miekus K, et al,. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005; 23: 879-94.
31. Hermann PC, Huber SL, Herrler T, et al,. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1: 313-23.
32. Liang Z, Zhan W, Zhu A, et al,. Development of a unique small molecule modulator of CXCR4. PLOS ONE 2012; 7: e34038.
33. Emery CM, Vijayendran KG, Zipser MC, et al,. MEK1 mutations confer resistance to MEK and B-RAF inhibition. Proc Natl Acad Sci U.S.A. 2009; 106: 20411-16.